Search results
Found 380 matches for
Oxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants’ Partner James Mallinson join Orbit’s Board of Directors.
Stefan Piechnik
CVM OCMR Principal Investigators
DSc, PhD, MScEE, FSCMR Stefan Piechnik - Professor of Biomedical Imaging
Betty Raman
CVM OCMR Principal Investigators
MBBS DPhil FESC FRACP Betty Raman - Associate Professor of Cardiovascular Medicine
Naveed Akbar
CVM Principal Investigators
BSc (Hons), MSc, PhD, FHEA Naveed Akbar - ASSOCIATE PROFESSOR OF CARDIOVASCULAR SCIENCE
Elizabeth Ormondroyd
CVM Principal Investigators
PhD; MSc Genetic Counselling Elizabeth Ormondroyd - Principal Investigator in RDM; Senior researcher; Genetic counsellor
Timothy Betts
CVM Principal Investigators
MD, MBChB, FRCP Timothy Betts - Associate Professor of Cardiovascular Medicine
Parag Gajendragadkar
CVM Researchers
MA, MB BChir, MPhil (Cantab), DPhil (Oxon), MRCP Parag Gajendragadkar - Senior Clinical Fellow in Electrophysiology
Svetlana Reilly
CVM Principal Investigators
MD DPhil (Oxon) Svetlana Reilly - Associate Professor of Cardiovascular Science and British Heart Foundation Senior Research Fellow
Yiangos Psaras
CVM Students
BSc (Hons), MSc, DPhil Yiangos Psaras - Oxford-BMS Post-Doctoral Research Fellow